And the secretion of IL-1β and IL-18, caused by activation of the NLRP3 inflammasome, is emerging as a powerful determinant of metabolic inflammation and insulin resistance in T2DM patients (Stienstra et al., 2010; Wen et al., 2011). The gene discussed is IL1B; the disease is Insulin resistance.